US2009081256A1PendingUtilityA1
Transgenic plant-based vaccines
Est. expiryOct 7, 2017(expired)· nominal 20-yr term from priority
A61K 2039/6037C07K 14/62C12N 15/8258A61K 48/00C07K 2319/55C07K 14/28C12N 9/88A61K 39/12C07K 2319/00C12N 15/8216A61P 29/00C12N 2720/12334A61K 39/00
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of inducing partial or complete immunity to an infectious disease in a mammal comprising providing to the mammal for oral consumption an effective amount of a protein complex comprising five monomeric fusion proteins.
Claims
exact text as granted — not AI-modified1 . A method of producing an immunogen in a plant comprising cultivating a transgenic plant transformed with a DNA construct that encodes, upon expression in a plant cell, a protein complex comprising a multimeric cholera toxin B subunit and a an immunogenic antigen from a causal factor of a first mammalian disease under conditions effective to express the protein complex.
2 . A method of producing an immunogen in a plant comprising cultivating a transgenic plant transformed with a DNA construct that encodes, upon expression in a plant cell, a protein complex comprising a cholera toxin A2 subunit, a multimeric cholera toxin B subunit, a first immunogenic antigen from a causal factor of a first mammalian disease, and a second immunogenic antigen from a causal factor of a second mammalian disease under conditions effective to express the protein complex.
3 . The method of claim 1 , where the multimeric cholera toxin B subunit comprises five monomeric fusion proteins.
4 . The method of claim 3 , where the immunogenic antigen is NSP4 antigen from rotavirus, and where each fusion protein further comprises a cholera toxin B subunit linked to an NSP4 antigen from rotavirus.
5 . The method of claim 3 , where the protein complex further comprises ETEC fimbrial antigen CFA/1 from enterotoxigenic E. coli.
6 . The method of claim 1 , where the DNA construct comprises a bidirectional promoter controlling transcription of the DNA construct.
7 . A plant produced according to the method of claim 1 .
8 . A plant produced according to the method of claim 3 .
9 . A plant produced according to the method of claim 4 .
10 . A plant produced according to the method of claim 5 .
11 . A plant produced according to the method of claim 6 .
12 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 7 .
13 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 8 .
14 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 9 .
15 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 10 .
16 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 11 .
17 . The method of claim 2 , where the multimeric cholera toxin B subunit comprises five monomeric fusion proteins.
18 . The method of claim 17 , where the first immunogenic antigen is NSP4 antigen from rotavirus, and where each fusion protein further comprises a cholera toxin B subunit linked to an NSP4 antigen from rotavirus.
19 . The method of claim 17 , where the second immuogenic antigen is ETEC fimbrial antigen CFA/1 from enterotoxigenic E. coli.
20 . The method of claim 2 , where the DNA construct comprises a bidirectional promoter controlling transcription of the DNA construct.
21 . A plant produced according to the method of claim 2 .
22 . A plant produced according to the method of claim 17 .
23 . A plant produced according to the method of claim 18 .
24 . A plant produced according to the method of claim 19 .
25 . A plant produced according to the method of claim 20 .
26 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 21 .
27 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 22 .
28 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 23 .
29 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 24 .
30 . A method for the prevention of multiple types of acute gastroenteritis simultaneously in a mammal comprising providing to the mammal for oral consumption an effective amount of the plant of claim 25 .Join the waitlist — get patent alerts
Track US2009081256A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.